Frontiers in Oncology | Genitourinary Oncology

Original Research

Published on 27 Feb 2024

Deep learning-based radiomics model from pretreatment ADC to predict biochemical recurrence in advanced prostate cancer

in Genitourinary Oncology

Huihui Wang
Kexin Wang
Yaofeng Zhang
Yuke Chen
Xiaodong Zhang
Xiaoying Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1342104

1,475 views
1 citation

Original Research

Published on 26 Feb 2024

Predictive value of volumetric parameters based on 18F-PSMA-1007 PET/CT for prostate cancer metastasis

in Genitourinary Oncology

Yanmei Li
Jian Chen
Xiaojuan Wang
Pengfei Yang
Jiqin Yang
Qian Zhao
Juan Li

Frontiers in Oncology

doi 10.3389/fonc.2024.1335205

1,161 views

Original Research

Published on 21 Feb 2024

BioPrev-C – development and validation of a contemporary prostate cancer risk calculator

in Genitourinary Oncology

Thomas Hermanns
Marian S. Wettstein
Basil Kaufmann
Noémie Lautenbach
Ernest Kaufmann
Karim Saba
Florian A. Schmid
Andreas M. Hötker
Michael Müntener
Martin Umbehr

Frontiers in Oncology

doi 10.3389/fonc.2024.1343999

870 views

Original Research

Published on 21 Feb 2024

Predictive value of controlling nutritional status score for prostate cancer diagnosis

in Genitourinary Oncology

Jiaguo Huang
Ji Sun
Runmiao Hua
Yi Fan
Kai Wang
Liying Zheng
Biao Qian

Frontiers in Oncology

doi 10.3389/fonc.2024.1268800

946 views

Original Research

Published on 21 Feb 2024

Genomic amplifications identified by circulating tumor DNA analysis guide prognosis in metastatic castration-resistant prostate cancer

in Genitourinary Oncology

Toros A. Dincman
Joseph A. Q. Karam
Antonio Giordano
Hong Li
Leylah M. Drusbosky
Theodore S. Gourdin
Philip H. Howe
Michael B. Lilly

Frontiers in Oncology

doi 10.3389/fonc.2023.1202277

1,967 views

Original Research

Published on 20 Feb 2024

Lower baseline testosterone level is related to earlier development of castration resistance in metastatic prostate cancer: a multi-center cohort study

in Genitourinary Oncology

Ho Ming Chris Wong
Peter Ka-Fung Chiu
Ignacio Puche-Sanz
Zhao Xue
Dong-Ning Chen
Enrique Gomez-Gomez
Isabel Heidegger
Mona Kafka
Yong Wei
Shinichi Sakamoto

Frontiers in Oncology

doi 10.3389/fonc.2024.1321522

1,498 views
1 citation

Original Research

Published on 15 Feb 2024

Absence of GATA3/FOXA1 co-expression predicts poor prognosis in upper tract urothelial carcinoma

in Genitourinary Oncology

Yue Wang
Yunfan Wang
Huiying He
Yan Xiong

Frontiers in Oncology

doi 10.3389/fonc.2024.1302864

1,230 views

Case Report

Published on 15 Feb 2024

Case report: Enfortumab vedotin induced refractory DKA and multi organ failure – a rare fatal adverse event

in Genitourinary Oncology

Astha Koolwal Kapoor
Carleton S. Ellis
Deepali Pandey
Derek B. Allison
Zin W. Myint

Frontiers in Oncology

doi 10.3389/fonc.2024.1332478

2,275 views
5 citations

Original Research

Published on 12 Feb 2024

Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study

in Genitourinary Oncology

Veronica Murianni
Alessio Signori
Sebastiano Buti
Sara Elena Rebuzzi
Davide Bimbatti
Ugo De Giorgi
Silvia Chiellino
Luca Galli
Paolo Andrea Zucali
Cristina Masini

Frontiers in Oncology

doi 10.3389/fonc.2024.1307635

1,797 views

Case Report

Published on 12 Feb 2024

Case report: Ectopic corpus cavernosum presented as bladder tumor in a 3-year-old boy

in Genitourinary Oncology

Jia-gui Chai
Yan-liang Zhao
Si-fan Yin
Zhi-yuan Yin
Shen-zhao Zhao
Run-lin Feng
Chang-xing Ke

Frontiers in Oncology

doi 10.3389/fonc.2024.1308493

1,023 views

Editorial

Published on 07 Feb 2024

Editorial: Circulating biomarkers in prostate cancer

in Genitourinary Oncology

Masayoshi Nagata
Shigeo Horie
Yafeng Ma

Frontiers in Oncology

doi 10.3389/fonc.2024.1365353

1,146 views

Case Report

Published on 02 Feb 2024

Acquired cystic disease-associated renal cell carcinoma with PTCH1 mutation: a case report

in Genitourinary Oncology

Luting Zhou
Haimin Xu
Yang Liu
Xiangyun Li
Chuanying Li
Xiaoqun Yang
Chaofu Wang

Frontiers in Oncology

doi 10.3389/fonc.2024.1349610

1,456 views

Original Research

Published on 02 Feb 2024

Clinical efficacy analysis of partial cystectomy and radical cystectomy in the treatment of muscle-invasive sarcomatoid carcinoma of the urinary bladder

in Genitourinary Oncology

Jiansheng Xiao
Hua Chen
Jiaqi Ge
Tairong Liu

Frontiers in Oncology

doi 10.3389/fonc.2024.1324487

1,125 views
1 citation

Original Research

Published on 01 Feb 2024

Retrospective study on the toxicity induced by stereotactic body radiotherapy: overview of the reunion experience on prostate cancer in elderly patients

in Genitourinary Oncology

Youssef Slama
Gilles Baumont
Angelique Arcambal
Mickael Begue
Olivier Maillot
Rima Sayah
Romain Castanet
Raoul Caboche
Pedro Liberati
Hakim Slaoui

Frontiers in Oncology

doi 10.3389/fonc.2024.1302001

1,159 views

Original Research

Published on 31 Jan 2024

Clinical significance of serum high sensitive C-reactive protein/albumin ratio in primary prostate biopsy

in Genitourinary Oncology

Xinyang Chen
Yu Li
Gang Li
Xuefeng Zhang
Gansheng Xie
Yuhua Huang
Huming Yin

Frontiers in Oncology

doi 10.3389/fonc.2024.1325524

1,380 views
2 citations

Review

Published on 31 Jan 2024

Addressing the risk and management of cardiometabolic complications in prostate cancer patients on androgen deprivation therapy and androgen receptor axis-targeted therapy: consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology

in Genitourinary Oncology

Darren M. C. Poon
Guang-Ming Tan
Kuen Chan
Marco T. Y. Chan
Tim-Wai Chan
Raymond W. M. Kan
Martin H. C. Lam
Clarence L. H. Leung
Kenneth C. W. Wong
Kevin K. H. Kam

Frontiers in Oncology

doi 10.3389/fonc.2024.1345322

3,420 views
2 citations

Navigation group

Articles

Deep learning-based radiomics model from pretreatment ADC to predict biochemical recurrence in advanced prostate cancer

Predictive value of volumetric parameters based on 18F-PSMA-1007 PET/CT for prostate cancer metastasis

BioPrev-C – development and validation of a contemporary prostate cancer risk calculator

Predictive value of controlling nutritional status score for prostate cancer diagnosis

Genomic amplifications identified by circulating tumor DNA analysis guide prognosis in metastatic castration-resistant prostate cancer

Lower baseline testosterone level is related to earlier development of castration resistance in metastatic prostate cancer: a multi-center cohort study

Absence of GATA3/FOXA1 co-expression predicts poor prognosis in upper tract urothelial carcinoma

Case report: Enfortumab vedotin induced refractory DKA and multi organ failure – a rare fatal adverse event

Time to strategy failure and treatment beyond progression in pretreated metastatic renal cell carcinoma patients receiving nivolumab: post-hoc analysis of the Meet-URO 15 study

Case report: Ectopic corpus cavernosum presented as bladder tumor in a 3-year-old boy

Editorial: Circulating biomarkers in prostate cancer

Acquired cystic disease-associated renal cell carcinoma with PTCH1 mutation: a case report

Clinical efficacy analysis of partial cystectomy and radical cystectomy in the treatment of muscle-invasive sarcomatoid carcinoma of the urinary bladder

Retrospective study on the toxicity induced by stereotactic body radiotherapy: overview of the reunion experience on prostate cancer in elderly patients

Clinical significance of serum high sensitive C-reactive protein/albumin ratio in primary prostate biopsy

Addressing the risk and management of cardiometabolic complications in prostate cancer patients on androgen deprivation therapy and androgen receptor axis-targeted therapy: consensus statements from the Hong Kong Urological Association and the Hong Kong Society of Uro-Oncology